Social Media

Twitter Feed

In @PharmaVOICE's latest Woman of the Week podcast, @tgrom sat down with our Chief Clinical Development Officer, Kellie Malloy, to discuss her expertise in the CRO industry and our clinical programs for #cancers with limited treatment options. Listen here:

Our visceral lesion applicator (VLA) platform has the potential to change the treatment paradigm for #cancer by delivering potent immunotherapy directly to tumors and potentially increasing responses to existing therapies. Learn about our VLA technology:

In today’s #WoW podcast, Kellie Malloy Foerter, Chief Clinical Development Officer @OncoSec Medical discusses ongoing clinical studies in breast cancer treatment, hopes for intratumoral therapy, and leadership skills.

After two decades working in the #CRO industry, tomorrow’s #WoW podcast guest, Kellie Malloy Foerter, Chief Clinical Development Officer, @OncoSec Medical, is tracking exciting new ways to evaluate potential cancer treatments. Listen in tomorrow!